Uncategorized

Zepbound Outperforms Wegovy in Weight Loss Trial

Posted on:

In a recent head-to-head clinical trial, Eli Lilly’s Zepbound demonstrated superior weight loss outcomes compared to Novo Nordisk’s Wegovy. Participants using tirzepatide, marketed as Zepbound, lost an average […]